EVP R&D, Chief Medical Officer
Mon, Mar 2, 2026
Mar 2
5,000 shares @ $19.34
Increased holdings by +5.40%
60th largest trade (out of 152)
Cluster Buy
Trade made by an officer
Part of a cluster of 18 transactions by 6 insiders
10b5-1 scheduled trade
41% win rate · -4.2% median edge vs SPY (22 trades, 90-day)
Insider trade was 36% below market price